通知本文はこちら（PDF）
Contents
1. 3 V ero2. CFU 1 0 Mycoplasma hyorhinis A TTCC
3. 2 4 2 8C 6 0 A 1 2 1I 1 I 2 2 I Mycoplasma pneumoniae
4. Q NG G G 6 7 G 6 Q G KO 4 1 5 2 3 G Q Wt NV QE G SH KG G G NG 3 1 1 1 2 2 2 0 5 0 9 4 8mL
5. amp PP GQ G Q 8S 8 N Q 8S Ae8 N 9 8 R gt 8 0 NW om WO NY 1 K SH AS Q IO NV IQ KG o HN SG Q NT 8 a SH SG Q 6 Q G NK HE HK G HH SH NA GS 9
6. nF m pe G GWK Q 1 S 4 5 4 4 an
7. WKG 4 5 4 4 Q Si amp m Q G G 8 nF 4 5 4 4 J S WK Q N Q
8. bisbenzamide 400 600 3 C
9. IT IT 4 2 100CFU 3 5 3 7 7 4 2 4 3
10. J mW 3 8S S 8S 0 3 4 1 1 1 0mL 1 2 5mL 2 G 4 5 4 4 w a m Q MKG G p Q yo KG 7 Q NO7 G h Q 0 Q 7
11. Q SN 5 2 G S KW SRKNN G Q QG SG C perfringens WEL6 perfringens NH TC septicuml l WW C 9 2 HH C oe dema t iens WTC oedema tie ns NH TC histolyticum S TC histolyticum NO G 6 Q KG 6 6 NO S Q N9 68 mm RS 3 3 1 3 1 300 400g 4 1 5mL 3 0 1mL
12. 4 1 4 2 4 3 4 1 4 2 4 1 1 0 2m 1 1 0 3 5 3 7 5 10vo 1 4 2 1 0m 1I L 1 0 1 0 2mL 3 5 3 7 1 4 5 7 1 0 2mL 1 4
13. 1 0 RS 0 Ne 3 3 3 2 8 83 2 2 Em ee 0 5mL SFE CC IDgi CC I Di 1 Q Q G KO 5 2 G NNKRN G KG 8S oo mR BQ 5 3 G 8 Q 8S NAS n S amp S 2 MV
14. 3 GQ S 8 m 8 amp 2 3 Q HH HN 8 3 Q Q Q 0 NY HAD mw 2 5 10mg 5 0 20mg o 4
15. 0 2w v 8S O 8S oOo oeor ro 3 Car Q FE 10000mL 1000mL SnKAAZ7 9KA77 1 1 sgd g aog 8 Q 50mg S 1 g Q Oo 3 MN NR S 8 Q F 7 1 g mL 1 g L 1 0 0 0 5mL 4 5mL 1g mL G O G O Or o a KN G 5 G HANK G I M pneumon iae
16. Q WW VM 3 Sh9 WM 3 VM S G G o
17. MIE I Sh 7 NTGO29082 ATOGCIZ9ei Mycoplasma ora7e ATCC23714 1 0 0CFU 2 2 1 1 X1 0 m 1 5 1 3 5 3 8 2 2 Myco plasma hyorhinis ATCC29052 ATCC17981 Mycoplasma ora7e ATCC23714 1 0 0 CFU 5 3 5 38 3 6 2 83 a L000
18. NMR OSL 5 2 p HN S KR G NG G G Q Q KG KG Q Q A 6 C 8 Q Q Q Q NRN NA R 8 Q
19. 1 0 2 C perfringens Type A 1 2 3 29 7 2 8S NSRKNV O 0 Ar oSH RR Q C septicum 7os rr7g7p septicum C septicum 1 0 5 septicum 1 2 3 2 9 7 2 8S NSRKNV O oo Se Ssermo ga WR SQ C oege ar7ens 7os tridium oedematiens
20. VQ 8 Sn S 4 5 44 NR 0 Q 5 2 G GMK 6 m G G 0S 8 8 n Q lo 4 5 4 4 7
21. K S G H KR S O7 0 6 OO 1 3 3 RRO mn 0 6 Q 8 2 11 3 2 1 0 3 2 10 3 2 9 Q oo Q Q Q Q Q Q Q Q Q
22. 2 0 G 12 RS In 6 K 8 NO nano mg G ROmn XG mMhMKG OO HA SWART7 0 6 8 1 0 9 3 8 2 1 12 10 6 42 n S amp S NG G OO RNN G Q G Q
23. M ora 1 e 100CFU 3 5 3 7 7 NG
24. 1 G K9 B 8 1 0 K922G 8 G 00 NG 1 1 1 0G Q em 8 8 ho Q 2 2 NO G o TLPU Leucocyte promoting unit SMO S S JJ
25. Q Q NYO RS n 2 QO Q Du DU Sm m oo 8 2 10 3 2 9 o 8 2 11 38 2 10 m 08 2 1 IS 2 IS8 OY NE 15 2 12 2 T18 2 11 2 MN 183 2 8 3 2 11 3 8 2 13 3 2 NG Q
26. mMKG PANNN AGW Q GS Sho 5 2 KG NN SW o m Q Q SO NG SQ6 NG 9 S 3 Vero Q Q Qe G 6 Q 8
27. S RN 0 m0 NN GQ G G G ARK97 G G GQ EU mL S SG G WHO G G 6 ksHNK SMGT
28. oedematiens 1 0 0 2 oege aje n s 1 23 2 9 7 2 Q GS G SN 3 G 1 O 8S Oo R EN gt R Oo OO o a oo 8 0 0 2 w v9 Dulbecco pH7 4
29. 200Lf 1 2m G NN 6S Q 0 3 1 3 2 0 2w v 0 0 1 7mo 1 pH7 0 4 0 0 1m 2 0 4 Okg 2 2 G NN 6S Q y01 3 2 6 3 7 20 3 1 3 2 6 NN 6 Q o ip NO KG AN 6 o
30. Q Q Q OO Q Q Q MN OM NM NMIY Q Q oo Q SA4Q0 O Q Q SG O Q m Q Q Oo G G 0 GW Oo 3 2 6 2 3 2 6 RSIm 0 NAS mm ofF 3 2 6 2 3 2 6 56 MG 0 AN Q JJ SS Q Q 8 2 1 0 3 2 9 Q 0 Q Q 13 2 6 2
31. Q 0 O 8 RS NG 3 2 2 3 2 2 1 35 1 41 0 0 5 1 0 3 2 2 2 1 1 1 2 3 5 1 4 8 3 mm G RN G Q Q Q Q Q a 0 0067mo1 L pH7 6 6 mn RE ON SQ 5 3
32. 3 2 6 Q Q Q Q m Q Q Q MN NM NN mM Q NWN NN mM NN NN NO Q Q Q Q Q Q Q Q Q Q Q m Q Q Q m Q8 0 Q Q Q Q Q Q 4 7 m L 28 mL O Q Q Q Q QJ O Q Q QO Q Q Q Q Q Q Q Q Q Q Q Q Q Q EGO mm Ss NE 3 2 12 2 1 NN AS 2 11 2 1 1 8 NN NN
33. mm Q oo Q 20 Q Q po 9 H o G Q Q SNQ N Q MG KG 88 G Q JJ Q 83 3 83 2 83 83 2 2 Q Q 3 3 3 2 3 3 2 2 2L o o S JJ C o 0 5mL SF TCCIDso TCCIDso 8 amp LT
34. QQ Q G 3 3 3 2 3 3 2 2 m 0 5mL GFE CCIDs CC ID S lt Q G SNO7 5 2 G 6 N Q 0 5 mL CCIDso CCIDso w NN RE OQ 5 2 G G m 0 5mL 8 CCIDso CCIDso S amp S
35. S 1mL 8 Sh 1 4 m 1 CA WI WW 1 X 1 G SRSRKN NV O Rok moa Fao RSQ per7r7 pjge s Type GO7 os DEITIES e A perfringens Type A
36. 1 4 1 0 2 0 1mL 4 1 4 3 0 1 m pH7 2 10mL 3 2 2 100mL 1 IL 4 2 5 1 4 7
37. He LO nHMMKG SH AS G SSH AG NS FR NW SO MMO NVQ NN 0 MWD NA GS NN 9 CO 4 NN 0 NM G mm eo SH G Q 6 Q G lt 6 SHTN Q KN9 NG H S 6 HN Q QMO NA FG o He NRN 9 HN SG SS 3 NG SHN oo lt S
38. NG G AN 6 SQ NG 8 8 mn Q G AN 6 SQ NG G 1 6 K AG 5 1 1 NN RE NA SQ 5 2 NK NK TEF N Q NO TN G Q 0 0067mol LL pH7 6 Q NG G AR G Q NO NN
39. 20 50 20 0 2mL 4 1 C 100000g 90 0 2 5mL 2 5m 2 5m G HH Q Q Q Q QU mm Q
40. NN NN NN EROO NN Ns Ss 3 2 12 2 1 3 US 2 11 2 1 3 NN MM NN NN MA Q NA OD MN NN NO NN m 0 a AO WWw Q Q Q m Q Q Q 29 O Q Q Q Q 2 7 mL 18 mL Q Q O Q NM NMM NN NNO Q Q Q 83 2 12 3 1 1 NT T3 2 11 3 1 1 Q 2 NN NO EN NET 3 2 1 2 3 1 2 NTT3 2 11 3 1 2 Q Q Q Q NAO 1T9 2 12 3 1 3 2 1 8 2 11 3 1 3 Q Q Q Q Q Q nm 8 2 12 83 2 11
41. S 2 NG7 U G Q Q Q Q w 9 S G 8S m NT N G Mm OSN oG 1 4V 1 4 hG 6 6 Q WKG 6 6 G 6 MG 8 TS Sn Q G G KG GW o NG
42. SoS o Fao NR NS NS NG C perfringens Type 2 7os 7 er gens 7 pe A S R8S K NP 9 Saeno8 RE RCL SQ C septicum 7os tridium septicum G 6 QG K SWD S oo Ngeernn oa NR HN NS C oedema tiens Clostridium oedematiens G mQ SG QGA
43. m KG 1 LA EA 1 2 10 8 amp TE 8 SG Oe 8 oo 4 SG 5 1 6 0 36LPU 48HSU 1368BWDU HSU BWDU R8S KRM O Ao hm hm
44. 29052 ATCC17981 G G G NO PFU FFU CCIDs SC G G 3 2 W 1 1
45. ATCC15531 I I Myco plasma ora7e ATCC2371 4 100 C F 3 5 3 7 7 100 CFU 1 4 3 A4c o7ep 7asmg 7g7 7awr7j Acholeplasma laidlawi 1 Acholeplasma 7a7 7awrr
Download Pdf Manuals
Related Search